» Articles » PMID: 34126999

Utilization of the Evidence from Studies with No Events in Meta-analyses of Adverse Events: an Empirical Investigation

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2021 Jun 15
PMID 34126999
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Backgrounds: Zero-events studies frequently occur in systematic reviews of adverse events, which consist of an important source of evidence. We aimed to examine how evidence of zero-events studies was utilized in the meta-analyses of systematic reviews of adverse events.

Methods: We conducted a survey of systematic reviews published in two periods: January 1, 2015, to January 1, 2020, and January 1, 2008, to April 25, 2011. Databases were searched for systematic reviews that conducted at least one meta-analysis of any healthcare intervention and used adverse events as the exclusive outcome. An adverse event was defined as any untoward medical occurrence in a patient or subject in healthcare practice. We summarized the frequency of occurrence of zero-events studies in eligible systematic reviews and how these studies were dealt with in the meta-analyses of these systematic reviews.

Results: We included 640 eligible systematic reviews. There were 406 (63.45%) systematic reviews involving zero-events studies in their meta-analyses, among which 389 (95.11%) involved single-arm-zero-events studies and 223 (54.93%) involved double-arm-zero-events studies. The majority (98.71%) of these systematic reviews incorporated single-arm-zero-events studies into the meta-analyses. On the other hand, the majority (76.23%) of them excluded double-arm-zero-events studies from the meta-analyses, of which the majority (87.06%) did not discuss the potential impact of excluding such studies. Systematic reviews published at present (2015-2020) tended to incorporate zero-events studies in meta-analyses than those published in the past (2008-2011), but the difference was not significant (proportion difference=-0.09, 95% CI -0.21 to 0.03, p = 0.12).

Conclusion: Systematic review authors routinely treated studies with zero-events in both arms as "non-informative" carriers and excluded them from their reviews. Whether studies with no events are "informative" or not largely depends on the methods and assumptions applied, thus sensitivity analyses using different methods should be considered in future meta-analyses.

Citing Articles

Comparative Genomic Analysis of Livestock-Derived : Antimicrobial Resistance, Virulence, Mobile Genetic Elements, and Genetic Relatedness.

An J, Lee J, Cho S, Song H J Microbiol Biotechnol. 2025; 35:e2411044.

PMID: 39947677 PMC: 11876010. DOI: 10.4014/jmb.2411.11044.


The Role of Double-Zero-Event Studies in Evidence Synthesis: Evaluating Robustness Using the Fragility Index.

Wang Z, Xing X, Mun E, Wu C, Lin L J Eval Clin Pract. 2025; 31(1):e14301.

PMID: 39780615 PMC: 11735258. DOI: 10.1111/jep.14301.


A Commentary on "Cervical Rotation-Traction Manipulation for Cervical Radiculopathy: A Systematic Review and Meta-Analysis of Randomized Control Trials" [Letter].

Mou Y, Liu Z, Ma R J Pain Res. 2024; 17:4493-4494.

PMID: 39735656 PMC: 11675369. DOI: 10.2147/JPR.S510465.


Assessment of inverse publication bias in safety outcomes: an empirical analysis.

Xing X, Zhu J, Shi L, Xu C, Lin L BMC Med. 2024; 22(1):494.

PMID: 39456055 PMC: 11515227. DOI: 10.1186/s12916-024-03707-2.


Harm effects in non-registered versus registered randomized controlled trials of medications: a retrospective cohort study of clinical trials.

Xu C, Fan S, Furuya-Kanamori L, Li S, Lin L, Chu H BMC Med. 2024; 22(1):450.

PMID: 39394146 PMC: 11470660. DOI: 10.1186/s12916-024-03621-7.


References
1.
Egger M, Smith G, Phillips A . Meta-analysis: principles and procedures. BMJ. 1998; 315(7121):1533-7. PMC: 2127925. DOI: 10.1136/bmj.315.7121.1533. View

2.
Xiao M, Lin L, Hodges J, Xu C, Chu H . Double-zero-event studies matter: A re-evaluation of physical distancing, face masks, and eye protection for preventing person-to-person transmission of COVID-19 and its policy impact. J Clin Epidemiol. 2021; 133:158-160. PMC: 8137366. DOI: 10.1016/j.jclinepi.2021.01.021. View

3.
Xu C, Li L, Lin L, Chu H, Thabane L, Zou K . Exclusion of studies with no events in both arms in meta-analysis impacted the conclusions. J Clin Epidemiol. 2020; 123:91-99. DOI: 10.1016/j.jclinepi.2020.03.020. View

4.
Bhaumik D, Amatya A, Normand S, Greenhouse J, Kaizar E, Neelon B . Meta-Analysis of Rare Binary Adverse Event Data. J Am Stat Assoc. 2013; 107(498):555-567. PMC: 3665366. DOI: 10.1080/01621459.2012.664484. View

5.
Altman D, Bland J . Missing data. BMJ. 2007; 334(7590):424. PMC: 1804157. DOI: 10.1136/bmj.38977.682025.2C. View